Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients
about
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoidsTwo decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.Exploring the role of microglia in mood disorders associated with experimental multiple sclerosisAltered function of monocytes/macrophages in patients with autoimmune hepatitis.Previous infection with Staphylococcus aureus strains attenuated experimental encephalomyelitis.The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.Myeloid cells - targets of medication in multiple sclerosis.Strategies to increase the activity of microglia as efficient protectors of the brain against infections.Comparing the biological impact of glatiramer acetate with the biological impact of a generic.Guidelines for the use of flow cytometry and cell sorting in immunological studies.Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's disease.Monocyte/macrophage lineage commitment and distribution are affected by the lack of regulatory T cells in scurfy mice.[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].
P2860
Q28647160-3EE52BB2-CBA3-45B1-8E65-6A65D8D77EB5Q34090086-8966E7C9-736E-446F-8313-A3511B9A2C8AQ34473419-B9F6E1A1-C9D2-4C6E-A8FC-5C67B308D936Q35777988-533D555D-5A3F-4CBF-8449-27C0CCB636EBQ36817364-5BE6639E-3B5A-4991-97F2-9B8026B43CFBQ37474212-67D9F5AD-E1CB-4192-9DA4-0A1C293A69ACQ38116543-CAC4351F-1595-48AA-A89C-7A0ABF718981Q38152977-8006DCBF-C06A-4868-828B-CD9ABC81DD50Q38924828-DB99D81A-B26C-405B-9D0E-FA357E731363Q39924370-78E2AD48-E9FF-4446-B982-659EBC2761A0Q41860072-555497AC-FA78-493E-8B7A-322ADDBB0AD4Q41918189-95231BC6-5EA1-43F3-9760-77BDC659F890Q42496183-7690872C-8A6B-40ED-A4D8-2E12701335C9Q45885554-286A7216-6D2B-4599-953A-B0FD96F4829BQ52855510-E21C2AB1-065B-48D7-9739-1BE2CEA83925
P2860
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Glatiramer acetate increases p ...... in multiple sclerosis patients
@ast
Glatiramer acetate increases p ...... in multiple sclerosis patients
@en
Glatiramer acetate increases p ...... in multiple sclerosis patients
@nl
type
label
Glatiramer acetate increases p ...... in multiple sclerosis patients
@ast
Glatiramer acetate increases p ...... in multiple sclerosis patients
@en
Glatiramer acetate increases p ...... in multiple sclerosis patients
@nl
prefLabel
Glatiramer acetate increases p ...... in multiple sclerosis patients
@ast
Glatiramer acetate increases p ...... in multiple sclerosis patients
@en
Glatiramer acetate increases p ...... in multiple sclerosis patients
@nl
P2093
P2860
P1433
P1476
Glatiramer acetate increases p ...... in multiple sclerosis patients
@en
P2093
Corinna Trebst
Elke Verena Voss
Franco Morbiducci
Jelena Škuljec
Martin Stangel
Niklas Garde
Thomas Skripuletz
Ute Diederichs
Vikramjeet Singh
P2860
P304
P356
10.1371/JOURNAL.PONE.0051867
P407
P577
2012-12-20T00:00:00Z